Back
Anavex Alzheimer's Drug Shows 84.7% Benefit in Trial
Back
Stock News
Themes
Anavex Alzheimer's Drug Shows 84.7% Benefit in Trial
Asset Management
Anavex Alzheimer's Drug Shows 84.7% Benefit in Trial
Edgen Stock
·
Jan 15 2026, 10:16
Share to
Share to
Copy link
AVXL
+4.33%
source:
[1] Anavex Life Sciences Highlights Oral Alzheimer’s Drug Blarcamesine, Precision Strategy at JPM Conference
Recommend
Hong Kong Refinancing Jumps 26-Fold to HK$26 Billion
Jan 18 2026, 22:25
Meta's $72B Spending Plan Draws Scrutiny as BofA Sets $810 Target
Jan 18 2026, 22:03
Bloom Energy Stock Gains 72% on Data Center Demand
Jan 18 2026, 21:55
Edgen Stock·Jan 15 2026, 10:16Edgen Stock·Jan 15 2026, 10:16
Edgen Stock·Jan 15 2026, 10:16